Primary prevention implantable cardioverter-defibrillators and survival in older women.

[1]  L. Stevenson,et al.  Abstract 11117: Outcomes Among Medicare Beneficiaries are Optimized When Primary ICD Implant Occurs During an Elective Rather Than Unplanned Hospitalization , 2013 .

[2]  S. Bhavnani,et al.  The Gender‐Paradox among Patients with Implantable Cardioverter‐Defibrillators: A Propensity‐Matched Study , 2013, Pacing and clinical electrophysiology : PACE.

[3]  John Rumsfeld,et al.  The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. , 2013, Heart rhythm.

[4]  K. Anstrom,et al.  Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. , 2013, JAMA.

[5]  J. Messenger,et al.  The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. , 2012, Journal of the American College of Cardiology.

[6]  Kevin L. Thomas,et al.  Trends in Use of Implantable Cardioverter-Defibrillator Therapy Among Patients Hospitalized for Heart Failure: Have the Previously Observed Sex and Racial Disparities Changed Over Time? , 2012, Circulation.

[7]  P. Austin,et al.  Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database , 2012, Annals of Internal Medicine.

[8]  Harlan M Krumholz,et al.  National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. , 2011, JAMA.

[9]  Sana M. Al-Khatib,et al.  Non-evidence-based ICD implantations in the United States. , 2011, JAMA.

[10]  A. Natale,et al.  Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. , 2010, Heart rhythm.

[11]  C. O'connor,et al.  Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure , 2010, Circulation. Heart failure.

[12]  H. Ghanbari,et al.  Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. , 2009, Archives of internal medicine.

[13]  Adrian F Hernandez,et al.  Representativeness of a National Heart Failure Quality-of-Care Registry: Comparison of OPTIMIZE-HF and Non–OPTIMIZE-HF Medicare Patients , 2009, Circulation. Cardiovascular quality and outcomes.

[14]  Adrian F Hernandez,et al.  Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. , 2009, American heart journal.

[15]  C. Albert,et al.  Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy. , 2008, American heart journal.

[16]  D. Mark,et al.  Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure Trial , 2008, Journal of cardiovascular electrophysiology.

[17]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[18]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[19]  R. Redberg.  Disparities in use of implantable cardioverter-defibrillators: moving beyond process measures to outcomes data. , 2007, JAMA.

[20]  C. Yancy,et al.  Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. , 2007, JAMA.

[21]  K. Schulman,et al.  Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. , 2007, JAMA.

[22]  B. Lindsay,et al.  Review of the registry's first year, data collected, and future plans. , 2007, Heart rhythm.

[23]  Paul J. Wang,et al.  The Effect of Gender on Mortality or Appropriate Shock in Patients with Nonischemic Cardiomyopathy Who Have Implantable Cardioverter‐Defibrillators , 2007, Pacing and clinical electrophysiology : PACE.

[24]  C. White,et al.  The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death , 2006, Journal of internal medicine.

[25]  J. Ruskin,et al.  Clinical Course and Implantable Cardioverter Defibrillator Therapy in Postinfarction Women with Severe Left Ventricular Dysfunction , 2005, Journal of cardiovascular electrophysiology.

[26]  Daniel B. Mark,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure , 2005 .

[27]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[28]  C. O'connor,et al.  Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. , 2004, American heart journal.

[29]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[30]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[31]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[32]  D. Rubin,et al.  Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score , 1985 .

[33]  W. Frishman,et al.  Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure , 2007 .

[34]  Wojciech Zareba,et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.